Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Actinium Pharmaceuticals Inc

+ Add to Watchlist

ATNM:US

2.8900 USD 0.1400 4.62%

As of 20:04:04 ET on 05/22/2015.

Snapshot for Actinium Pharmaceuticals Inc (ATNM)

Open: 3.1000 Day's Range: 2.7800 - 3.1500 Volume: 928,022
Previous Close: 3.0300 52wk Range: 2.3100 - 13.7000 1-Yr Rtn: -75.92%

Stock Chart for ATNM

No chart data available.
  • ATNM:US 2.8900
  • 1D
  • 1M
  • 1Y
3.0300
Interactive ATNM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATNM

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3800
Est. EPS (USD) (12/2015) -0.6450
Est. PEG Ratio -
Market Cap (M USD) 103.59
Shares Outstanding (M) 35.85
30 Day Average Volume 484,757
Price/Book (mrq) 6.2750
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATNM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATNM

Actinium Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company develops alpha particle immunotherapeutics and other radiopharmaceuticals for select applications.

Sandesh SethChairmanKaushik J DavePresident/CEO/Interim CFO
Dragan CicicCOO/Chief Medical Officer
More Company Profile & Key Executives for ATNM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil